X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1631) 1631
Publication (81) 81
Book Review (24) 24
Newspaper Article (8) 8
Newsletter (5) 5
Magazine Article (4) 4
Book Chapter (3) 3
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lansoprazole (1433) 1433
humans (1302) 1302
male (1025) 1025
female (904) 904
gastroenterology & hepatology (773) 773
adult (745) 745
omeprazole (739) 739
middle aged (734) 734
proton pump inhibitors (680) 680
pharmacology & pharmacy (615) 615
index medicus (598) 598
2-pyridinylmethylsulfinylbenzimidazoles (524) 524
omeprazole - analogs & derivatives (490) 490
aged (480) 480
treatment outcome (413) 413
helicobacter infections - drug therapy (371) 371
anti-ulcer agents - therapeutic use (352) 352
helicobacter pylori (352) 352
omeprazole - therapeutic use (323) 323
rabeprazole (281) 281
drug therapy, combination (280) 280
gastroesophageal reflux - drug therapy (258) 258
anti-ulcer agents - administration & dosage (254) 254
proton pump inhibitor (240) 240
omeprazole - administration & dosage (229) 229
infection (222) 222
pantoprazole (218) 218
double-blind method (215) 215
medicine & public health (214) 214
adolescent (199) 199
gastroesophageal reflux (192) 192
esomeprazole (191) 191
pharmacokinetics (190) 190
prospective studies (189) 189
proton pump inhibitors - therapeutic use (185) 185
efficacy (172) 172
gastroesophageal-reflux disease (169) 169
helicobacter pylori - drug effects (169) 169
eradication (168) 168
amoxicillin - therapeutic use (166) 166
anti-bacterial agents - therapeutic use (166) 166
clarithromycin (166) 166
double-blind (166) 166
amoxicillin (164) 164
proton pump inhibitors - administration & dosage (162) 162
therapy (162) 162
drug administration schedule (158) 158
clarithromycin - therapeutic use (154) 154
dose-response relationship, drug (152) 152
2-pyridinylmethylsulfinylbenzimidazoles - therapeutic use (151) 151
omeprazole - pharmacology (151) 151
aged, 80 and over (147) 147
cross-over studies (146) 146
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (140) 140
management (139) 139
ranitidine (139) 139
triple therapy (138) 138
hydrogen-ion concentration (136) 136
gastroenterology (133) 133
time factors (133) 133
anti-ulcer agents - pharmacology (132) 132
young adult (129) 129
animals (124) 124
internal medicine (124) 124
gastroesophageal reflux disease (121) 121
amoxicillin - administration & dosage (117) 117
anti-ulcer agents - adverse effects (117) 117
oncology (115) 115
cytochrome p-450 cyp2c19 (113) 113
omeprazole - adverse effects (113) 113
esophagitis (112) 112
clarithromycin - administration & dosage (111) 111
anti-bacterial agents - administration & dosage (110) 110
proton pump inhibitors - adverse effects (105) 105
administration, oral (103) 103
care and treatment (103) 103
disease (101) 101
erosive esophagitis (101) 101
hepatology (98) 98
duodenal-ulcer (97) 97
helicobacter infections - complications (97) 97
helicobacter infections - microbiology (97) 97
drug interactions (96) 96
metronidazole (96) 96
pharmacology/toxicology (96) 96
genotype (94) 94
aryl hydrocarbon hydroxylases - genetics (91) 91
cyp2c19 (91) 91
symptoms (90) 90
proton pump inhibitors - pharmacology (89) 89
enzyme inhibitors - therapeutic use (88) 88
medicine, general & internal (88) 88
gastric acidity determination (87) 87
drug therapy (86) 86
follow-up studies (86) 86
helicobacter-pylori infection (85) 85
intragastric ph (83) 83
health aspects (82) 82
analysis (81) 81
anti-ulcer agents - pharmacokinetics (81) 81
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1621) 1621
Japanese (26) 26
French (14) 14
Korean (5) 5
German (4) 4
Russian (2) 2
Chinese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 02/2003, Volume 17, Issue 1, pp. 24 - 24
Introduction : Esomeprazole, the first proton pump inhibitor to be developed as an optical isomer, has demonstrated more effective healing vs. omeprazole and... 
GASTROENTEROLOGY & HEPATOLOGY | PHARMACOLOGY & PHARMACY | Dose-Response Relationship, Drug | Double-Blind Method | Esomeprazole - administration & dosage | Esophagitis, Peptic | Humans | 2-Pyridinylmethylsulfinylbenzimidazoles | Lansoprazole | Anti-Ulcer Agents - administration & dosage
Journal Article
Journal Article